Sympathetic nervous system in obesity-related hypertension: mechanisms and clinical implications

被引:153
|
作者
Kalil, Graziela Z.
Haynes, William G. [1 ,2 ]
机构
[1] Univ Iowa, Dept Internal Med, Carver Coll Med, Div Endocrinol, Iowa City, IA 52242 USA
[2] Univ Iowa, Dept Internal Med, Carver Coll Med, Div Cardiovasc Med, Iowa City, IA 52242 USA
关键词
mechanisms; obesity; sympathetic; therapy; TYPE-2; DIABETES-MELLITUS; BODY-MASS INDEX; ANGIOTENSINOGEN GENE-EXPRESSION; SELECTIVE LEPTIN RESISTANCE; CIRCULATING GHRELIN LEVELS; PLACEBO-CONTROLLED TRIAL; LIPID-LOWERING TREATMENT; MEDIATED VASCULAR-TONE; DIET-INDUCED OBESITY; LONG-TERM EFFICACY;
D O I
10.1038/hr.2011.173
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Obesity markedly increases the risk of hypertension and cardiovascular disease, which may be related to activation of the sympathetic nervous system (SNS). Sympathetic overactivity directly and indirectly contributes to blood pressure (BP) elevation in obesity, including stimulation of the renin-angiotensin-aldosterone system (RAAS). The adipocyte-derived peptide leptin suppresses appetite, increases thermogenesis, but also raises SNS activity and BP. Obese individuals exhibit hyperleptinemia but are resistant to its appetite-suppressing actions. Interestingly, animal models of obesity exhibit preserved sympathoexcitatory and pressor actions of leptin, despite resistance to its anorexic and metabolic actions, suggesting selective leptin resistance. Disturbance of intracellular signaling at specific hypothalamic neural networks appears to underlie selective leptin resistance. Delineation of these pathways should lead to novel approaches to treatment. In the meantime, treatment of obesity-hypertension has relied on antihypertensive drugs. Although sympathetic blockade is mechanistically attractive in obesity-hypertension, in practice its effects are disappointing because of adverse metabolic effects and inferior outcomes. On the basis of subgroup analyses of obese patients in large randomized clinical trials, drugs such as diuretics and RAAS blockers appear superior in preventing cardiovascular events in obesity-hypertension. An underused alternative approach to obesity-hypertension is induction of weight loss, which reduces circulating leptin and insulin, partially reverses resistance to these hormones, decreases sympathetic activation and improves BP and other risk factors. Though weight loss induced by lifestyle is often modest and transient, carefully selected pharmacological weight loss therapies can produce substantial and sustained antihypertensive effects additive to lifestyle interventions. Hypertension Research (2012) 35, 4-16; doi:10.1038/hr.2011.173; published online 3 November 2011
引用
收藏
页码:4 / 16
页数:13
相关论文
共 50 条
  • [1] Sympathetic nervous system in obesity-related hypertension: mechanisms and clinical implications
    Graziela Z Kalil
    William G Haynes
    [J]. Hypertension Research, 2012, 35 : 4 - 16
  • [2] The role of the sympathetic nervous system in obesity-related hypertension
    Alexandre A. da Silva
    Jussara do Carmo
    John Dubinion
    John E. Hall
    [J]. Current Hypertension Reports, 2009, 11
  • [3] The role of the sympathetic nervous system in obesity-related hypertension
    da Silva, Alexandre A.
    do Carmo, Jussara
    Dubinion, John
    Hall, John E.
    [J]. CURRENT HYPERTENSION REPORTS, 2009, 11 (03) : 206 - 211
  • [4] Obesity-related hypertension: Role of the sympathetic nervous system, insulin, and leptin
    Kazuko Masuo
    [J]. Current Hypertension Reports, 2002, 4 : 112 - 118
  • [5] Obesity-related hypertension: Role of the sympathetic nervous system, insulin, and leptin
    Masuo, K
    [J]. CURRENT HYPERTENSION REPORTS, 2002, 4 (02) : 112 - 118
  • [6] Mechanisms of sympathetic activation in obesity-related hypertension
    Esler, Murray
    Straznicky, Nora
    Eikelis, Nina
    Masuo, Kazuko
    Lambert, Gavin
    Lambert, Elisabeth
    [J]. HYPERTENSION, 2006, 48 (05) : 787 - 796
  • [8] The mechanisms in obesity-related hypertension
    Masuo, K
    Kawaguchi, H
    Ogihara, T
    Tuck, ML
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 37 (02) : 241A - 241A
  • [9] Mechanisms of obesity-related hypertension
    Lamounier-Zepter, V
    Bornstein, SR
    Ehrhart-Bornstein, M
    [J]. HORMONE AND METABOLIC RESEARCH, 2004, 36 (06) : 376 - 380
  • [10] Mechanisms mediating renal sympathetic nerve activation in obesity-related hypertension
    Chen, W.
    Leo, S.
    Weng, C.
    Yang, X.
    Wu, Y.
    Tang, X.
    [J]. HERZ, 2015, 40 : 190 - 196